Preclinical evaluation of the <scp>BET</scp> bromodomain inhibitor <scp>BAY</scp> 1238097 for the treatment of lymphomaElena Bernasconi(Institute of Oncology Research), Francesco Bertoni(Institute of Oncology Research)British Journal of HaematologyJune 27, 201710.1111/bjh.14803Cited by 40SaveCiteExport RISWatch citationsRelated PapersCopanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models|Blood Advances|2020|41